In chlorpromazine-derived cholestasis, increased MRP4 expression has been observed, along with a decreased expression of NTCP (SLC10A1), to avoid the influx of more BAs (Antherieu et al. 2013). The gene discussed is SLC10A1; the disease is cholestasis.